Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

M.D. ANDERSON CANCER CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies

Phase 2

Completed

Conditions: Leukemia
Lymphoma
Stem Cell Transplantation

Interventions: Drug: Thiotepa
Drug: Clofarabine
Drug: Busulfan
Procedure: Allogeneic Stem Cell Transplantation
Drug: Thymoglobulin (ATG)
Drug: G-CSF (Filgrastim)
Drug: Tacrolimus
Drug: Methotrexate
Drug: Cyclophosphamide
Drug: Mesna

First Posted Date: 2009-03-06

Last Posted Date: 2020-04-07

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 60

Registration Number: NCT00857389

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Expressive Disclosure and Colorectal Cancer

Conditions: Colorectal Cancer

Interventions: Behavioral: Interviews
Behavioral: Questionnaires
Behavioral: Group Meetings
Other: Electronically Activated Recorder (EAR)
Behavioral: Written Materials

First Posted Date: 2009-03-02

Last Posted Date: 2020-12-21

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 174

Registration Number: NCT00853203

Locations: 🇺🇸
Kelsey-Seybold Clinics, Houston, Texas, United States
🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Project CASA in Promoting Smoke-Free Indoor Air Policy in Mexican American Households

Not Applicable

Completed

Conditions: Cigarette Smoker
Current Smoker
Currently Living With Smoker

Interventions: Behavioral: Smoking Cessation Intervention
Other: Informational Intervention
Other: Survey Administration

First Posted Date: 2009-02-25

Last Posted Date: 2023-09-28

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 168

Registration Number: NCT00850954

Locations: 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States

Radiation Therapy for Rising Prostate Specific Antigen (PSA) Post-prostatectomy

Conditions: Prostate Cancer

Interventions: Behavioral: Questionnaire

First Posted Date: 2009-02-25

Last Posted Date: 2019-05-15

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 146

Registration Number: NCT00850941

Locations: 🇺🇸
Kaseman Presbyterian Hospital, Albuquerque, New Mexico, United States
🇺🇸
Spartanburg Regional Healthcare System, Spartanburg, South Carolina, United States
🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Initiative for Molecular Profiling in Advanced Cancer Therapy (IMPACT) Trial, An Umbrella Protocol

Conditions: Advanced Cancers

Interventions: Other: Molecular Profiling Analyses

First Posted Date: 2009-02-25

Last Posted Date: 2019-05-14

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 5000

Registration Number: NCT00851032

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Validating M.D. Anderson Symptom Inventory (MDASI-GI) in GI Cancer Patients Under Chemotherapy

Not Applicable

Completed

Conditions: Gastrointestinal Cancer

Interventions: Behavioral: Questionnaire
Other: Interview

First Posted Date: 2009-02-24

Last Posted Date: 2012-07-30

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 184

Registration Number: NCT00849979

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Genetic Susceptibility to Bladder Cancer

Active, not recruiting

Conditions: Bladder Cancer

Interventions: Behavioral: Interviews

First Posted Date: 2009-02-20

Last Posted Date: 2025-01-28

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 6086

Registration Number: NCT00848289

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States

Motion Correction of Positron Emission Tomography (PET) Data Using Amplitude Gating

Completed

Conditions: Lung Cancer

Interventions: Procedure: PET/CT Scan

First Posted Date: 2009-02-13

Last Posted Date: 2016-02-17

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 12

Registration Number: NCT00843219

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Colon Cancer Screening in First-Degree Relatives of Hispanic Colorectal Cancer (CRC) Patients

Completed

Conditions: Colorectal Cancer

Interventions: Behavioral: Interview

First Posted Date: 2009-02-06

Last Posted Date: 2012-07-30

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 26

Registration Number: NCT00838318

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Ancillary Study GOG 158: Survival Analysis Based on Reclassification to a Two-Tier Grading System

Completed

Conditions: Ovarian Cancer

First Posted Date: 2009-02-06

Last Posted Date: 2012-12-21

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 241

Registration Number: NCT00837993

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy